0001916558 2026-01-01 2026-06-30 0001916558 2026-08-19 0001916558 2026-06-30 0001916558 2025-12-31 0001916558 2026-04-01 2026-06-30 0001916558 2025-04-01 2025-06-30 0001916558 2025-01-01 2025-06-30 0001916558 TRWD:ManagementFeeIncomeMember 2026-04-01 2026-06-30 0001916558 TRWD:ManagementFeeIncomeMember 2025-04-01 2025-06-30 0001916558 TRWD:ManagementFeeIncomeMember 2026-01-01 2026-06-30 0001916558 TRWD:ManagementFeeIncomeMember 2025-01-01 2025-06-30 0001916558 TRWD:DistributionIncomeMember 2026-04-01 2026-06-30 0001916558 TRWD:DistributionIncomeMember 2025-04-01 2025-06-30 0001916558 TRWD:DistributionIncomeMember 2026-01-01 2026-06-30 0001916558 TRWD:DistributionIncomeMember 2025-01-01 2025-06-30 0001916558 us-gaap:ProductMember 2026-04-01 2026-06-30 0001916558 us-gaap:ProductMember 2025-04-01 2025-06-30 0001916558 us-gaap:ProductMember 2026-01-01 2026-06-30 0001916558 us-gaap:ProductMember 2025-01-01 2025-06-30 0001916558 us-gaap:CommonStockMember 2024-12-31 0001916558 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001916558 TRWD:StockSubscriptionsReceivableMember 2024-12-31 0001916558 us-gaap:RetainedEarningsMember 2024-12-31 0001916558 2024-12-31 0001916558 us-gaap:CommonStockMember 2025-03-31 0001916558 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001916558 TRWD:StockSubscriptionsReceivableMember 2025-03-31 0001916558 us-gaap:RetainedEarningsMember 2025-03-31 0001916558 2025-03-31 0001916558 us-gaap:CommonStockMember 2025-12-31 0001916558 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001916558 TRWD:StockSubscriptionsReceivableMember 2025-12-31 0001916558 us-gaap:RetainedEarningsMember 2025-12-31 0001916558 us-gaap:CommonStockMember 2026-03-31 0001916558 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001916558 TRWD:StockSubscriptionsReceivableMember 2026-03-31 0001916558 us-gaap:RetainedEarningsMember 2026-03-31 0001916558 2026-03-31 0001916558 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001916558 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001916558 TRWD:StockSubscriptionsReceivableMember 2025-01-01 2025-03-31 0001916558 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001916558 2025-01-01 2025-03-31 0001916558 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001916558 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001916558 TRWD:StockSubscriptionsReceivableMember 2025-04-01 2025-06-30 0001916558 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001916558 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001916558 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001916558 TRWD:StockSubscriptionsReceivableMember 2026-01-01 2026-03-31 0001916558 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001916558 2026-01-01 2026-03-31 0001916558 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001916558 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001916558 TRWD:StockSubscriptionsReceivableMember 2026-04-01 2026-06-30 0001916558 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001916558 us-gaap:CommonStockMember 2025-06-30 0001916558 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001916558 TRWD:StockSubscriptionsReceivableMember 2025-06-30 0001916558 us-gaap:RetainedEarningsMember 2025-06-30 0001916558 2025-06-30 0001916558 us-gaap:CommonStockMember 2026-06-30 0001916558 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001916558 TRWD:StockSubscriptionsReceivableMember 2026-06-30 0001916558 us-gaap:RetainedEarningsMember 2026-06-30 0001916558 us-gaap:CommonStockMember 2026-01-01 2026-06-30 0001916558 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-06-30 0001916558 TRWD:ConsultingExpenseMember 2026-01-01 2026-06-30 0001916558 TRWD:OperatingSegmentMember 2026-01-01 2026-06-30 0001916558 TRWD:OperatingSegmentMember 2025-01-01 2025-06-30 0001916558 us-gaap:CommonStockMember 2026-06-30 0001916558 TRWD:NonAffiliatedEntityMember 2025-06-07 2025-06-08 0001916558 TRWD:NonAffiliatedIndividualMember 2025-06-07 2025-06-09 0001916558 TRWD:NonAffiliatedIndividualMember 2025-07-04 2025-07-05 0001916558 TRWD:NonAffiliatedEntityMember 2025-07-07 2025-07-08 0001916558 TRWD:NonAffiliatedIndividualMember 2025-07-28 2025-07-29 0001916558 TRWD:NonAffiliatedEntityMember 2025-08-19 2025-08-20 0001916558 TRWD:NonAffiliatedIndividualMember 2025-09-22 2025-09-23 0001916558 TRWD:NonAffiliatedEntityMember 2025-10-09 2025-10-10 0001916558 us-gaap:CommonStockMember 2025-10-15 0001916558 TRWD:NonAffiliatedEntityMember 2025-10-14 2025-10-15 0001916558 TRWD:NonAffiliatedIndividualMember 2025-10-29 2025-11-01 0001916558 TRWD:NonAffiliatedIndividualMember 2025-11-02 2025-11-03 0001916558 TRWD:NonAffiliatedIndividualMember 2025-11-11 2025-11-12 0001916558 TRWD:NonAffiliatedIndividualMember 2025-11-27 2025-11-28 0001916558 TRWD:NonAffiliatedIndividualMember 2026-01-22 2026-01-23 0001916558 TRWD:NonAffiliatedIndividualMember 2026-01-27 2026-01-28 0001916558 TRWD:NonAffiliatedIndividualMember 2026-04-12 2026-04-13 0001916558 TRWD:NonAffiliatedIndividualMember 2026-04-14 2026-04-15 0001916558 TRWD:NonAffiliatedIndividualMember 2026-04-14 2026-04-16 0001916558 TRWD:NonAffiliatedIndividualMember 2026-06-16 2026-06-17 0001916558 TRWD:NonAffiliatedInvestorMember 2026-01-20 2026-01-21 0001916558 2026-04-13 0001916558 us-gaap:NoteWarrantMember 2026-06-30 0001916558 us-gaap:NoteWarrantMember 2026-01-01 2026-06-30 0001916558 TRWD:WarrantsMember 2026-01-01 2026-06-30 0001916558 TRWD:WarrantsMember 2026-06-30 0001916558 TRWD:Warrants1Member 2026-01-01 2026-06-30 0001916558 TRWD:Warrants1Member 2026-06-30 0001916558 TRWD:Warrants2Member 2026-01-01 2026-06-30 0001916558 TRWD:Warrants2Member 2026-06-30 0001916558 TRWD:Warrants3Member 2026-01-01 2026-06-30 0001916558 TRWD:Warrants3Member 2026-06-30 0001916558 TRWD:Warrants4Member 2026-01-01 2026-06-30 0001916558 TRWD:Warrants4Member 2026-06-30 0001916558 TRWD:Warrants5Member 2026-01-01 2026-06-30 0001916558 TRWD:Warrants5Member 2026-06-30 0001916558 TRWD:Warrants6Member 2026-01-01 2026-06-30 0001916558 TRWD:Warrants6Member 2026-06-30 0001916558 TRWD:EquityLineOfCreditAgreementMember 2026-01-27 2026-01-29 0001916558 TRWD:EquityLineOfCreditAgreementMember 2026-01-29 0001916558 TRWD:EquityLineOfCreditAgreementMember 2026-01-20 2026-01-21 0001916558 TRWD:EquityLineOfCreditAgreementMember 2026-06-20 2026-06-21 0001916558 TRWD:EquityLineOfCreditAgreementMember 2026-01-21 iso4217:USD shares iso4217:USD shares pure TRWD:Integer false 2026 Q2 --12-31 0001916558

10-Q true 2026-06-30 false 333-276233 Tradewinds Universal WY 87-4254479 501 Mercury Lane Brea CA 92821 855 434-4488 Yes Yes Non-accelerated Filer true true false false 129810580

8636

16638

445

25445

70750

48750

79831

90833

170000

190000

25000 25000 1500 1500

196500

216500

276331

307333

27000

65000

92000

0.001

150000000

129810580

42690580

129811

42691

4412599

1447709

182810

-0

-4175269

-1183067

184331

307333

276331

307333

25000

12972

20000

6800

20000

15000

25000

20000

46800

32972

25000

20000

46800

32972

27287

10000

51083

10000

2814798

27200

2858498

39850

10000

1200

20000

2400

25724

853

90313

853

14051

5890

19107

6124

2891860

45143

3039001

59227

-2866860

-25143

-2992201

-26255

-2866860

-25143

-2992201

-26255

-0.02

0.00

-0.04

0.00

59337614

34670000

51416436

34670000

32170000

32170

289530

-290190

31510

-1112

32170000

32170

289530

-291302

30398

2500000

2500

22500

25000

-25143

34670000

34670

312030

-316445

30255

42690580

42691

1447709

-1183067

307333

1000000

1000

49000

50000

-125341

43690580

43691

1496709

-1308408

231992

1200000

1200

16800

18000

79000000

79000

2722200

2801200

5920000 5920 176890 -182810

-2866860

129810580

129811

4412599

-182810

-4175269

184331

-2992201

-26255

20000

2400

2801200 25000

22000

1025

-25000

-0

27000

-141002

120

-0

68000

65000

133000

-8002

120

16638

210

8636

330

0 0 182810 0

Note 1 – Nature of Operations Nature of Operations Tradewinds Universal, Inc. (the “Company”) was incorporated in the State of Wyoming on December 28, 2021. The Company operates as a holding company focused on acquiring, developing, and managing businesses with long-term value, resilience, and growth potential. The Company’s initial operations focused on the development and distribution of high-nutrition foods and beverages, including edible insect protein-based products. In 2022, the Company acquired a canine pain relief formula for development into pet-related products. During the year ended December 31, 2025, the Company expanded its strategic focus to include distribution and licensing activities. On August 19, 2025, we entered into a non-binding Letter of Intent, or LOI, with Scar Holdings LLC, also known as Peppermint Hippo™, regarding the potential formation of a division focused on the acquisition and development of nightlife and hospitality venues under the Peppermint Hippo brand. The first proposed acquisition contemplated by the LOI is Peppermint Hippo Toledo, located in Toledo, Ohio. The LOI further contemplates that we may, together with Peppermint Hippo, evaluate the possible acquisition of additional Peppermint Hippo-branded venues over time. The LOI is non-binding and no definitive acquisition agreement has been entered into with respect to Peppermint Hippo Toledo or any other venue. Completion of any acquisition would be subject to a number of conditions, including completion of due diligence, negotiation and execution of definitive agreements, receipt of required consents, financing, and regulatory and licensing approvals. As a result, there can be no assurance that we will complete the acquisition of Peppermint Hippo Toledo, pursue any additional acquisition opportunity with Peppermint Hippo, or otherwise establish a nightlife and hospitality division.

Note 2 - Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of the Company’s financial position as of June 30, 2026 and December 31, 2025 and the results of operations and cash flows for the three and six months ended June 30, 2026 and 2025 have been included. Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts. Accordingly, actual results could differ from those estimates. Cash And Cash Equivalents The Company maintains cash balances in non-interest-bearing accounts that currently do not exceed federally insured limits. For purposes of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered cash equivalents. There were no cash equivalents as of June 30, 2026, June 30, 2025, or December 31, 2025. Accounts Receivable Accounts receivable consist of trade receivables and are stated at the amount management expects to collect. As of June 30, 2026 and December 31, 2025, accounts receivable totaled $70,750 and $48,750, respectively. The Company evaluates accounts receivable for expected credit losses in accordance with ASC 326, Financial Instruments—Credit Losses. In estimating expected credit losses, management considers relevant available information, including historical collection experience, the financial condition and creditworthiness of the customer, current economic conditions, and reasonable and supportable forecasts of future conditions that may affect collectibility. Based on this evaluation, no allowance for credit losses was recorded as of June 30, 2026 or December 31, 2025. Prepaid Expenses Prepaid expenses consist primarily of payments made for services to be received in future periods and are expensed as the services are consumed. As of June 30, 2026 and December 31, 2025, prepaid expenses totaled $445 and $25,445, respectively. Intangible Asset Intangible assets are recorded at cost and amortized over their estimated useful lives unless determined to have an indefinite useful life. For definite-lived intangible assets, the Company evaluates impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If such indicators are present, the Company compares the expected undiscounted future cash flows attributable to the asset to its carrying amount. If the carrying amount exceeds the expected undiscounted future cash flows, an impairment loss is recognized for the amount by which the carrying amount exceeds the asset’s fair value. Indefinite-lived intangible assets are not amortized but are evaluated for impairment at least annually, or more frequently if events or changes in circumstances indicate that it is more likely than not that the asset is impaired. As of June 30, 2026, the Company’s intangible assets, net, totaled $196,500. During the six months ended June 30, 2026, the Company recorded amortization expense of $20,000 and no additions to intangible assets. <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">•</td> <td style="padding-bottom: 8pt">Intangible assets, gross $216,500</td></tr> <tr style="vertical-align: top"> <td> </td> <td>•</td> <td style="padding-bottom: 8pt">Less accumulated amortization $(20,000)</td></tr> <tr style="vertical-align: top"> <td> </td> <td>•</td> <td style="padding-bottom: 8pt">Intangible assets, net $196,500</td></tr> </table> Total intangible assets, net, were $196,500 as of June 30, 2026 and $216,500 as of December 31, 2025. The decrease reflects $20,000 of amortization expense recorded during the six months ended June 30, 2026. No additions to intangible assets and no impairment expense were recorded during the six months ended June 30, 2026 or 2025. As of June 30, 2025, the Company’s intangible assets totaled approximately $28,900, compared with $31,300 at December 31, 2024, reflecting $2,400 of amortization expense during the six-month period. Finite-lived intangible assets are amortized on a straight-line basis over their estimated useful lives. The Company’s AI application is amortized over five years, and the Company’s website was amortized over two years and was fully amortized as of December 31, 2025. Amortization expense was $20,000 for the six months ended June 30, 2026 and $2,400 for the six months ended June 30, 2025. Stock Compensation The Company accounts for stock-based compensation in accordance with ASC 718, Compensation—Stock Compensation. Stock-based compensation expense is recognized based on the fair value of equity instruments issued. The Company is authorized to issue 150,000,000 shares of common stock, par value $0.001 per share. As of June 30, 2026 and December 31, 2025, there were 129,810,580 and 42,690,580 shares of common stock issued and outstanding, respectively (see Note 5). During the six months ended June 30, 2026, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20260101__20260630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zh6GkVOU5jKi" title="Shares issued for services stock-based compensation">79,000,000 shares of common stock for services and recognized aggregate stock-based compensation of $2,801,200. The issuances increased common stock by $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20260101__20260630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zStar1Z2RYe6" title="Shares issued for services stock-based compensation, value">79,000 and additional paid-in capital by $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20260101__20260630__us-gaap--StatementClassOfStockAxis__us-gaap--AdditionalPaidInCapitalMember_zQo0LCWEUKI8" title="Shares issued for services stock-based compensation, value">2,722,200. Shares issued for cash and pursuant to the equity line of credit are not included in stock-based compensation. The Company recorded consulting expense of $<span id="xdx_90F_ecustom--StocksIssuedDuringPeriodValueIssuedForServices_c20260101__20260630__srt--ProductOrServiceAxis__custom--ConsultingExpenseMember_zECkBeAQ3789" title="Shares issued for services, value">2,858,498 during the six months ended June 30, 2026, including $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20260101__20260630__srt--ProductOrServiceAxis__custom--ConsultingExpenseMember_zmqk7j1GxFYe" title="Shares issued for services stock-based compensation, value">2,801,200 of stock-based compensation related to shares issued for services. The financial statements should be read together with Notes 5 and 6 regarding changes in common stock, additional paid-in capital, and stock subscriptions receivable. Impairment Of Long-Lived Assets The Company accounts for impairment of intangible assets in accordance with ASC 350, Intangibles—Goodwill and Other. Definite-lived intangible assets are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite-lived intangible assets are not amortized but are tested for impairment at least annually, or more frequently if events or changes in circumstances indicate potential impairment. As of June 30, 2026, the Company reviewed its finite- and indefinite-lived intangible assets for indicators of impairment. No impairment charge was recorded during the three or six months ended June 30, 2026 or 2025. Revenue Recognition The Company accounts for revenue in accordance with ASC 606, Revenue from Contracts with Customers. Under ASC 606, revenue is recognized when control of promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to receive in exchange for those goods or services. Revenue for the three months ended June 30, 2026 consisted of $25,000 of management fee income. Revenue for the six months ended June 30, 2026 consisted of $25,000 of management fee income, $6,800 of distribution income, and $15,000 of product sales. Revenue for the three months ended June 30, 2025 consisted of $20,000 of distribution income, and revenue for the six months ended June 30, 2025 consisted of $12,972 of management fee income and $20,000 of distribution income. For each contract, the Company first determines whether an arrangement exists that creates enforceable rights and obligations. The Company then identifies the distinct performance obligations promised in the contract. The transaction price is determined based on the consideration the Company expects to receive under the terms of the arrangement, including fixed amounts and, when applicable, estimates of variable consideration to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur. When a contract contains more than one performance obligation, the transaction price is allocated to each performance obligation based on its relative standalone selling price. Revenue from distribution rights is recognized at the point in time or over the period in which the customer obtains control of the contractual rights, depending on the nature of the arrangement and the Company’s performance obligations under the contract. Revenue from licenses is recognized when the licensed intellectual property is made available to the customer or over the license term, depending on whether the license provides a right to use intellectual property as it exists at a point in time or a right to access intellectual property as it evolves over time. Revenue from affiliate commissions is recognized at the time the underlying qualifying transaction occurs and the commission is earned, which is the point at which the Company’s performance obligation is satisfied. The Company evaluates each contract to determine whether it acts as principal or agent, as applicable, and records revenue on a gross or net basis consistent with that determination. Payment terms vary by contract but are generally due within 30 to 90 days. Amounts billed and collected in advance of satisfying the related performance obligations are recorded as deferred revenue. No deferred revenue was recorded as of June 30, 2026 or December 31, 2025. Fair Value of Financial Instruments ASC 825, Financial Instruments, requires disclosure of the fair value of certain financial instruments. The carrying amounts of cash and cash equivalents, accounts receivable, loan payable, and accounts payable approximate fair value because of the short-term maturities of these instruments. The Company applies ASC 820, Fair Value Measurement, which establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three levels: Level 1, quoted prices in active markets for identical assets or liabilities; Level 2, observable inputs other than quoted prices included in Level 1; and Level 3, unobservable inputs reflecting the Company’s own assumptions. As of June 30, 2026 and December 31, 2025, the Company had no financial instruments measured at fair value on a recurring basis. Income Taxes In accordance with ASC 740 Income Taxes, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in Income in the period that includes the enactment date. The Company has adopted the provisions set forth in ASC 740 to account for uncertainty in income taxes. In the preparation of income tax returns in federal and state jurisdictions, the Company asserts certain tax positions based on its understanding and interpretation of the income tax law. The taxing authorities may challenge such positions, and the resolution of such matters could result in recognition of Income tax expense in the Company's financial statements. Management believes it has used reasonable judgments and conclusions in the preparation of its income tax returns. The Company uses the "more likely than not" criterion for recognizing the tax benefit of uncertain tax positions and to establish measurement criteria for income tax benefits. The Company' s policy is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company had no accrual for interest or penalties on its balance sheets as of June 30, 2026 and December 31, 2025. The Company has incurred net operating losses and has established a full valuation allowance against its deferred tax assets. As a result, no income tax expense or benefit was recorded for the three or six months ended June 30, 2026 or 2025. Earnings Per Share of Common Stock Net loss per share is computed in accordance with ASC 260, Earnings Per Share. Basic net loss per share is calculated by dividing net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per share gives effect to potentially dilutive securities, including warrants, using the treasury stock method. Potentially dilutive securities were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive. Recently Adopted Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting pronouncements would have a material effect on the accompanying interim financial statements.

Basis of Presentation The accompanying unaudited interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of the Company’s financial position as of June 30, 2026 and December 31, 2025 and the results of operations and cash flows for the three and six months ended June 30, 2026 and 2025 have been included.

Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts. Accordingly, actual results could differ from those estimates.

Cash And Cash Equivalents The Company maintains cash balances in non-interest-bearing accounts that currently do not exceed federally insured limits. For purposes of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered cash equivalents. There were no cash equivalents as of June 30, 2026, June 30, 2025, or December 31, 2025.

Accounts Receivable Accounts receivable consist of trade receivables and are stated at the amount management expects to collect. As of June 30, 2026 and December 31, 2025, accounts receivable totaled $70,750 and $48,750, respectively. The Company evaluates accounts receivable for expected credit losses in accordance with ASC 326, Financial Instruments—Credit Losses. In estimating expected credit losses, management considers relevant available information, including historical collection experience, the financial condition and creditworthiness of the customer, current economic conditions, and reasonable and supportable forecasts of future conditions that may affect collectibility. Based on this evaluation, no allowance for credit losses was recorded as of June 30, 2026 or December 31, 2025.

70750

48750

Prepaid Expenses Prepaid expenses consist primarily of payments made for services to be received in future periods and are expensed as the services are consumed. As of June 30, 2026 and December 31, 2025, prepaid expenses totaled $445 and $25,445, respectively.

445

25445

Intangible Asset Intangible assets are recorded at cost and amortized over their estimated useful lives unless determined to have an indefinite useful life. For definite-lived intangible assets, the Company evaluates impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If such indicators are present, the Company compares the expected undiscounted future cash flows attributable to the asset to its carrying amount. If the carrying amount exceeds the expected undiscounted future cash flows, an impairment loss is recognized for the amount by which the carrying amount exceeds the asset’s fair value. Indefinite-lived intangible assets are not amortized but are evaluated for impairment at least annually, or more frequently if events or changes in circumstances indicate that it is more likely than not that the asset is impaired. As of June 30, 2026, the Company’s intangible assets, net, totaled $196,500. During the six months ended June 30, 2026, the Company recorded amortization expense of $20,000 and no additions to intangible assets. <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">•</td> <td style="padding-bottom: 8pt">Intangible assets, gross $216,500</td></tr> <tr style="vertical-align: top"> <td> </td> <td>•</td> <td style="padding-bottom: 8pt">Less accumulated amortization $(20,000)</td></tr> <tr style="vertical-align: top"> <td> </td> <td>•</td> <td style="padding-bottom: 8pt">Intangible assets, net $196,500</td></tr> </table> Total intangible assets, net, were $196,500 as of June 30, 2026 and $216,500 as of December 31, 2025. The decrease reflects $20,000 of amortization expense recorded during the six months ended June 30, 2026. No additions to intangible assets and no impairment expense were recorded during the six months ended June 30, 2026 or 2025. As of June 30, 2025, the Company’s intangible assets totaled approximately $28,900, compared with $31,300 at December 31, 2024, reflecting $2,400 of amortization expense during the six-month period. Finite-lived intangible assets are amortized on a straight-line basis over their estimated useful lives. The Company’s AI application is amortized over five years, and the Company’s website was amortized over two years and was fully amortized as of December 31, 2025. Amortization expense was $20,000 for the six months ended June 30, 2026 and $2,400 for the six months ended June 30, 2025.

196500

20000

216500

-20000

196500

216500

20000

28900

31300

2400

20000

2400

Stock Compensation The Company accounts for stock-based compensation in accordance with ASC 718, Compensation—Stock Compensation. Stock-based compensation expense is recognized based on the fair value of equity instruments issued. The Company is authorized to issue 150,000,000 shares of common stock, par value $0.001 per share. As of June 30, 2026 and December 31, 2025, there were 129,810,580 and 42,690,580 shares of common stock issued and outstanding, respectively (see Note 5). During the six months ended June 30, 2026, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20260101__20260630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zh6GkVOU5jKi" title="Shares issued for services stock-based compensation">79,000,000 shares of common stock for services and recognized aggregate stock-based compensation of $2,801,200. The issuances increased common stock by $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20260101__20260630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zStar1Z2RYe6" title="Shares issued for services stock-based compensation, value">79,000 and additional paid-in capital by $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20260101__20260630__us-gaap--StatementClassOfStockAxis__us-gaap--AdditionalPaidInCapitalMember_zQo0LCWEUKI8" title="Shares issued for services stock-based compensation, value">2,722,200. Shares issued for cash and pursuant to the equity line of credit are not included in stock-based compensation. The Company recorded consulting expense of $<span id="xdx_90F_ecustom--StocksIssuedDuringPeriodValueIssuedForServices_c20260101__20260630__srt--ProductOrServiceAxis__custom--ConsultingExpenseMember_zECkBeAQ3789" title="Shares issued for services, value">2,858,498 during the six months ended June 30, 2026, including $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20260101__20260630__srt--ProductOrServiceAxis__custom--ConsultingExpenseMember_zmqk7j1GxFYe" title="Shares issued for services stock-based compensation, value">2,801,200 of stock-based compensation related to shares issued for services. The financial statements should be read together with Notes 5 and 6 regarding changes in common stock, additional paid-in capital, and stock subscriptions receivable.

150000000

0.001

129810580

42690580

79000000

2801200

79000

2722200

2858498

2801200

Impairment Of Long-Lived Assets The Company accounts for impairment of intangible assets in accordance with ASC 350, Intangibles—Goodwill and Other. Definite-lived intangible assets are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite-lived intangible assets are not amortized but are tested for impairment at least annually, or more frequently if events or changes in circumstances indicate potential impairment. As of June 30, 2026, the Company reviewed its finite- and indefinite-lived intangible assets for indicators of impairment. No impairment charge was recorded during the three or six months ended June 30, 2026 or 2025.

Revenue Recognition The Company accounts for revenue in accordance with ASC 606, Revenue from Contracts with Customers. Under ASC 606, revenue is recognized when control of promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to receive in exchange for those goods or services. Revenue for the three months ended June 30, 2026 consisted of $25,000 of management fee income. Revenue for the six months ended June 30, 2026 consisted of $25,000 of management fee income, $6,800 of distribution income, and $15,000 of product sales. Revenue for the three months ended June 30, 2025 consisted of $20,000 of distribution income, and revenue for the six months ended June 30, 2025 consisted of $12,972 of management fee income and $20,000 of distribution income. For each contract, the Company first determines whether an arrangement exists that creates enforceable rights and obligations. The Company then identifies the distinct performance obligations promised in the contract. The transaction price is determined based on the consideration the Company expects to receive under the terms of the arrangement, including fixed amounts and, when applicable, estimates of variable consideration to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur. When a contract contains more than one performance obligation, the transaction price is allocated to each performance obligation based on its relative standalone selling price. Revenue from distribution rights is recognized at the point in time or over the period in which the customer obtains control of the contractual rights, depending on the nature of the arrangement and the Company’s performance obligations under the contract. Revenue from licenses is recognized when the licensed intellectual property is made available to the customer or over the license term, depending on whether the license provides a right to use intellectual property as it exists at a point in time or a right to access intellectual property as it evolves over time. Revenue from affiliate commissions is recognized at the time the underlying qualifying transaction occurs and the commission is earned, which is the point at which the Company’s performance obligation is satisfied. The Company evaluates each contract to determine whether it acts as principal or agent, as applicable, and records revenue on a gross or net basis consistent with that determination. Payment terms vary by contract but are generally due within 30 to 90 days. Amounts billed and collected in advance of satisfying the related performance obligations are recorded as deferred revenue. No deferred revenue was recorded as of June 30, 2026 or December 31, 2025.

25000

6800

15000

20000

12972

20000

Fair Value of Financial Instruments ASC 825, Financial Instruments, requires disclosure of the fair value of certain financial instruments. The carrying amounts of cash and cash equivalents, accounts receivable, loan payable, and accounts payable approximate fair value because of the short-term maturities of these instruments. The Company applies ASC 820, Fair Value Measurement, which establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three levels: Level 1, quoted prices in active markets for identical assets or liabilities; Level 2, observable inputs other than quoted prices included in Level 1; and Level 3, unobservable inputs reflecting the Company’s own assumptions. As of June 30, 2026 and December 31, 2025, the Company had no financial instruments measured at fair value on a recurring basis.

Income Taxes In accordance with ASC 740 Income Taxes, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in Income in the period that includes the enactment date. The Company has adopted the provisions set forth in ASC 740 to account for uncertainty in income taxes. In the preparation of income tax returns in federal and state jurisdictions, the Company asserts certain tax positions based on its understanding and interpretation of the income tax law. The taxing authorities may challenge such positions, and the resolution of such matters could result in recognition of Income tax expense in the Company's financial statements. Management believes it has used reasonable judgments and conclusions in the preparation of its income tax returns. The Company uses the "more likely than not" criterion for recognizing the tax benefit of uncertain tax positions and to establish measurement criteria for income tax benefits. The Company' s policy is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company had no accrual for interest or penalties on its balance sheets as of June 30, 2026 and December 31, 2025. The Company has incurred net operating losses and has established a full valuation allowance against its deferred tax assets. As a result, no income tax expense or benefit was recorded for the three or six months ended June 30, 2026 or 2025.

Earnings Per Share of Common Stock Net loss per share is computed in accordance with ASC 260, Earnings Per Share. Basic net loss per share is calculated by dividing net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per share gives effect to potentially dilutive securities, including warrants, using the treasury stock method. Potentially dilutive securities were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive.

Recently Adopted Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting pronouncements would have a material effect on the accompanying interim financial statements.

Note 3 - Commitments and Contingencies During the normal course of business, the Company may be exposed to litigation. When the Company becomes aware of potential litigation, it evaluates the merits of the case in accordance with ASC 450, Contingencies. As of June 30, 2026 and December 31, 2025, the Company was not aware of any contingent liabilities or commitments that required accrual or disclosure in the accompanying unaudited financial statements.

Note 4 - Segment Disclosure ASC 280, Segment Reporting, establishes standards for reporting information about operating segments. The Company manages its business on the basis of one reportable segment and derives revenues mainly from products, licensing rights, distribution rights, and affiliate commissions. The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is regularly evaluated by the chief operating decision maker (“CODM”). The Company’s CODM is its chief executive officer, who reviews financial information and operating plans for purposes of making operating decisions, evaluating financial performance, and allocating resources. The key measure of segment profit or loss that the CODM uses to allocate resources and assess performance is the Company’s net loss. Segment Disclosures for the Three Months Ended: <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z8kkrkujSVb6" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment Disclosure (Details)"> <tr style="vertical-align: bottom"> <td>Schedule of segment disclosures</td><td> </td> <td colspan="2" id="xdx_49E_20260101__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--OperatingSegmentMember_zeTz8zJfnuL6" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49C_20250101__20250630__us-gaap--StatementBusinessSegmentsAxis__custom--OperatingSegmentMember_zuIysKNk4jMa" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">June 30, 2025</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--RevenuesAbstract_iB_zhI92YPSHt6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; padding-left: 5.4pt">Sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zR0OCBcVy5Ph" style="vertical-align: bottom; background-color: White"> <td style="width: 66%; font-size: 10pt; padding-bottom: 1pt; padding-left: 5.4pt"> Revenues</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; font-size: 10pt; text-align: right">25,000</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; font-size: 10pt; text-align: right">20,000</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--Revenues_zS2WtaTPhreg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-left: 5.4pt">Net Sales</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">25,000</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">20,000</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--CostOfGoodsAndServicesSold_d0_zBsKyIx9ye46" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"> Cost of Goods Sold</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">—</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">—</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--GrossProfit_zyu4mzANYnil" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Gross Profit</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">25,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">20,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--SellingGeneralAndAdministrativeExpenseAbstract_iB_zFw5zCGSnsCb" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-left: 5.4pt">Sales, marketing and support</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--MarketingAndAdvertisingExpense_zrRf49Nu0jK5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"> Marketing costs</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">25,724</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">853</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--ProfessionalFees_zJYVYRaX1kQ4" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"> Professional fees</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">27,287</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">10,000</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AmortizationOfIntangibleAssets_z88o6GJoxUn" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-left: 5.4pt"> Amortization</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">10,000</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,200</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherGeneralExpense_zCsmaw95ShH8" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-left: 5.4pt"> Consulting</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">2,814,798</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">27,200</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--GeneralAndAdministrativeExpense_zoXljpdeOHAj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"> General and Administrative costs</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">14,051</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">5,890</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_z6IWFroNr1k3" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Net Income (Loss) Before Taxes</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(2,866,860</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(25,143</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr> </table>

<table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z8kkrkujSVb6" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment Disclosure (Details)"> <tr style="vertical-align: bottom"> <td>Schedule of segment disclosures</td><td> </td> <td colspan="2" id="xdx_49E_20260101__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--OperatingSegmentMember_zeTz8zJfnuL6" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49C_20250101__20250630__us-gaap--StatementBusinessSegmentsAxis__custom--OperatingSegmentMember_zuIysKNk4jMa" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">June 30, 2025</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--RevenuesAbstract_iB_zhI92YPSHt6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; padding-left: 5.4pt">Sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zR0OCBcVy5Ph" style="vertical-align: bottom; background-color: White"> <td style="width: 66%; font-size: 10pt; padding-bottom: 1pt; padding-left: 5.4pt"> Revenues</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; font-size: 10pt; text-align: right">25,000</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; font-size: 10pt; text-align: right">20,000</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--Revenues_zS2WtaTPhreg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-left: 5.4pt">Net Sales</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">25,000</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">20,000</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--CostOfGoodsAndServicesSold_d0_zBsKyIx9ye46" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"> Cost of Goods Sold</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">—</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">—</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--GrossProfit_zyu4mzANYnil" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Gross Profit</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">25,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">20,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--SellingGeneralAndAdministrativeExpenseAbstract_iB_zFw5zCGSnsCb" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-left: 5.4pt">Sales, marketing and support</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--MarketingAndAdvertisingExpense_zrRf49Nu0jK5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"> Marketing costs</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">25,724</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">853</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--ProfessionalFees_zJYVYRaX1kQ4" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"> Professional fees</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">27,287</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">10,000</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AmortizationOfIntangibleAssets_z88o6GJoxUn" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-left: 5.4pt"> Amortization</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">10,000</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,200</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherGeneralExpense_zCsmaw95ShH8" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-left: 5.4pt"> Consulting</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">2,814,798</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">27,200</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--GeneralAndAdministrativeExpense_zoXljpdeOHAj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"> General and Administrative costs</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">14,051</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">5,890</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_z6IWFroNr1k3" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Net Income (Loss) Before Taxes</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(2,866,860</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(25,143</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr> </table>

25000

20000

25000

20000

25000

20000

25724

853

27287

10000

1200

2814798

27200

14051

5890

-2866860

-25143

Note 5 – Stockholders' Equity The Company is authorized to issue 150,000,000 shares of common stock, par value $0.001 per share. As of June 30, 2026, there were 129,810,580 shares of common stock issued and outstanding. As of December 31, 2025, there were 42,690,580 shares issued and outstanding. Since January 1, 2025 through June 30, 2026, the Company issued shares for services, asset acquisitions, cash, and subscription consideration. During the six months ended June 30, 2026, the Company issued an aggregate of 87,120,000 shares of common stock and recorded an aggregate increase of $87,120 to common stock and $2,964,890 to additional paid-in capital. A stock subscription receivable of $182,810 was recorded as contra-equity. The net increase in stockholders’ equity resulting from the 2026 issuances, before the effect of net loss, was $2,869,200. The accompanying financial statements reflect 129,810,580 shares issued and outstanding as of June 30, 2026. Set forth below is information regarding the issuance and sales of securities without registration through June 30, 2026. No such sales involved the use of an underwriter, no advertising or public solicitation was involved, the securities bear a restrictive legend, and no commissions were paid in connection with the sale of any securities. The individual issuances are summarized below: • On June 8, 2025, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20250607__20250608__us-gaap--AwardTypeAxis__custom--NonAffiliatedEntityMember_zYUiYoXNRCPi" title="Number of shares issued for services">1,500,000 shares of common stock to a non-affiliated entity for services. • On June 9, 2025, the Company issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20250607__20250609__us-gaap--AwardTypeAxis__custom--NonAffiliatedIndividualMember_zCUZd88DwYd4" title="Number of shares issued for services">1,000,000 shares of common stock to a non-affiliated individual for services. • On July 5, 2025, the Company issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20250704__20250705__us-gaap--AwardTypeAxis__custom--NonAffiliatedIndividualMember_zcxczlW1yqkd" title="Number of shares issued for services">500,000 shares of common stock to a non-affiliated individual for services. • On July 8, 2025, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20250707__20250708__us-gaap--AwardTypeAxis__custom--NonAffiliatedEntityMember_zpUXIzKbHEIb" title="Number of shares issued for services">1,000,000 shares of common stock to a non-affiliated entity for services. • On July 29, 2025, the Company issued 66,667 shares of common stock to a non-affiliated individual for cash. • On August 20, 2025, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesPurchaseOfAssets_c20250819__20250820__us-gaap--AwardTypeAxis__custom--NonAffiliatedEntityMember_ztIQnnuWaH9g" title="Number of shares issued for asset">173,913 shares of common stock to a non-affiliated entity in exchange for an asset. • On September 23, 2025, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20250922__20250923__us-gaap--AwardTypeAxis__custom--NonAffiliatedIndividualMember_zCLM6dkabugk" title="Number of shares issued for services">200,000 shares of common stock to a non-affiliated individual for services. • On October 10, 2025, the Company issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20251009__20251010__us-gaap--AwardTypeAxis__custom--NonAffiliatedEntityMember_z3gyQkGSUQe2" title="Number of shares issued for services">500,000 shares of common stock to a non-affiliated entity for services. • On October 15, 2025, the Company issued an aggregate of 1,780,000 shares of common stock, consisting of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20251014__20251015__us-gaap--AwardTypeAxis__custom--NonAffiliatedEntityMember_z1kGJXGdHzak" title="Number of shares issued for services">1,500,000 shares issued to a non-affiliated entity for services and 280,000 shares issued to a non-affiliated individual for cash. • On November 1, 2025, the Company issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20251029__20251101__us-gaap--AwardTypeAxis__custom--NonAffiliatedIndividualMember_zyf1L3gn3yFl" title="Number of shares issued for services">1,400,000 shares of common stock to a non-affiliated individual for services. • On November 3, 2025, the Company issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20251102__20251103__us-gaap--AwardTypeAxis__custom--NonAffiliatedIndividualMember_zGRg5RDggY1d" title="Number of shares issued for services">1,000,000 shares of common stock to a non-affiliated individual for services. • On November 12, 2025, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20251111__20251112__us-gaap--AwardTypeAxis__custom--NonAffiliatedIndividualMember_zB4kCpcQaSW7" title="Number of shares issued for services">1,000,000 shares of common stock to a non-affiliated individual for services. • On November 28, 2025, the Company issued <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20251127__20251128__us-gaap--AwardTypeAxis__custom--NonAffiliatedIndividualMember_zbbYPluXAlk6" title="Number of shares issued for services">400,000 shares of common stock to a non-affiliated individual for cash. • On January 23, 2026, the Company issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260122__20260123__us-gaap--AwardTypeAxis__custom--NonAffiliatedIndividualMember_zmj4DUIduuwf" title="Number of shares issued for services">500,000 shares of common stock to a non-affiliated individual for cash. • On January 28, 2026, the Company issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260127__20260128__us-gaap--AwardTypeAxis__custom--NonAffiliatedIndividualMember_zU7Dqu4yCD2c" title="Number of shares issued for services">500,000 shares of common stock to a non-affiliated individual for cash. • On April 13, 2026, the Company issued 1,200,000 shares of common stock to a non-affiliated individual for cash. • On April 15, 2026, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20260414__20260415__us-gaap--AwardTypeAxis__custom--NonAffiliatedIndividualMember_zNXa1r0oXfGi" title="Number of shares issued for services">2,000,000 shares of common stock to a non-affiliated corporation for services. • On April 16, 2026, the Company issued <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20260414__20260416__us-gaap--AwardTypeAxis__custom--NonAffiliatedIndividualMember_zjCNYMwAjXDd" title="Number of shares issued for services">2,000,000 shares of common stock to a non-affiliated corporation for services. • On June 17, 2026, the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20260616__20260617__us-gaap--AwardTypeAxis__custom--NonAffiliatedIndividualMember_z30ixDrVqSW1" title="Number of shares issued for services">75,000,000 shares of common stock to an affiliated individual (Andrew Read, CEO) for services. • On June 21, 2026, the Company issued 5,920,000 shares of common stock to a non-affiliated investor pursuant to the equity line of credit agreement. The Company recorded aggregate consideration of $182,810. The consideration had not been collected as of June 30, 2026 and was recorded as a stock subscription receivable within stockholders’ equity. As of June 30, 2026, the Company had 129,810,580 shares of common stock issued and outstanding. Warrants During 2025, the Company issued warrants to purchase an aggregate of 946,667 shares of common stock to the Beling Family Trust. During the six months ended June 30, 2026, the Company issued additional warrants to purchase an aggregate of 2,200,000 shares of common stock to the Beling Family Trust, including a warrant issued on April 13, 2026 to purchase up to 1,200,000 shares of common stock at an exercise price of $0.015 per share. The April 13, 2026 warrant expires on April 13, 2029. A summary of warrant activity for the six months ended June 30, 2026 is as follows: <table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfStockholdersEquityNoteWarrantsActivityTextBlock_zh2gNF4RQ5Gc" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details - Warrant activity)"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left">Schedule of warrant activity</td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left; font-size: 8pt"> </td><td style="padding-bottom: 1pt; font-size: 8pt"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 64%; font-size: 10pt; text-align: left">Outstanding at December 31, 2025</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20260101__20260630_zQ7X4NUDKzDi" style="width: 14%; font-size: 10pt; text-align: right" title="Warrants outstanding, beginning balance">946,667</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20260101__20260630_zxIeBjuhafF6" style="width: 14%; font-size: 10pt; text-align: right" title="Weighted average exercise price, beginning balance">0.08</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left">Granted</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20260101__20260630_zxVgBF9f0Byj" style="font-size: 10pt; text-align: right" title="Warrants outstanding, Granted">2,200,000</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20260101__20260630_zSjbiCTHvTK2" style="font-size: 10pt; text-align: right" title="Weighted average exercise price, Granted">0.03</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left">Exercised</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_d0_c20260101__20260630_zuxkdIGhOkB" style="font-size: 10pt; text-align: right" title="Warrants outstanding, Granted">—</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_d0_c20260101__20260630_zKdpP8HkGBk3" style="font-size: 10pt; text-align: right" title="Weighted average exercise price, Exercised">—</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left">Expired</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d0_c20260101__20260630_zyy8H73PGiRf" style="font-size: 10pt; text-align: right" title="Warrants outstanding, Expired">—</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d0_c20260101__20260630_zGDBKuGIGPMl" style="font-size: 10pt; text-align: right" title="Weighted average exercise price, Expired">—</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left">Outstanding at June 30, 2026</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20260101__20260630_zlar4Seg0bYf" style="font-size: 10pt; text-align: right" title="Warrants outstanding, ending balance">3,146,667</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20260101__20260630_z2igjONcf518" style="font-size: 10pt; text-align: right" title="Weighted average exercise price, ending balance">0.05</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left">Exercisable at June 30, 2026</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20260630_zHedKcNCwkz5" style="font-size: 10pt; text-align: right" title="Warrants outstanding, Exercisable">3,146,667</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20260630_ztEyOyK9VWs9" style="font-size: 10pt; text-align: right" title="Weighted average exercise price, Exercisable">0.05</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table> A summary of warrant activity for the six months ended June 30, 2025 is as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: left"> </td><td style="vertical-align: bottom; font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"> </td><td style="vertical-align: bottom; padding-bottom: 1pt; font-size: 8pt; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"> </td><td style="vertical-align: bottom; width: 64%; text-align: left">Outstanding at December 31, 2025</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_d0_c20250101__20250630_zsay2LZlQRPb" style="width: 14%; text-align: right" title="Warrants outstanding, beginning balance">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%; font-size: 12pt"> </td> <td style="width: 1%; font-size: 12pt; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_d0_c20250101__20250630_zsaVHPq4uZAb" style="width: 14%; font-size: 12pt; text-align: right" title="Weighted average exercise price, beginning balance">—</td><td style="width: 1%; font-size: 12pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="vertical-align: bottom; text-align: left">Granted</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20250101__20250630_zdiTH3Pl1RK9" style="text-align: right" title="Warrants outstanding, Granted">—</td><td style="text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20250101__20250630_zcJMcjuqbvrf" style="font-size: 12pt; text-align: right" title="Weighted average exercise price, Granted">—</td><td style="font-size: 12pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td style="vertical-align: bottom; text-align: left">Exercised</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_d0_c20250101__20250630_z4KUgiFTpAWe" style="text-align: right" title="Warrants outstanding, Exercised">—</td><td style="text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_d0_c20250101__20250630_zetBN9SyIVUa" style="font-size: 12pt; text-align: right" title="Weighted average exercise price, Exercised">—</td><td style="font-size: 12pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="vertical-align: bottom; text-align: left">Expired</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d0_c20250101__20250630_zO96tciH2YC4" style="text-align: right" title="Warrants outstanding, Expired">—</td><td style="text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d0_c20250101__20250630_zLdvK6hreJm8" style="font-size: 12pt; text-align: right" title="Weighted average exercise price, Expired">—</td><td style="font-size: 12pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td style="vertical-align: bottom; text-align: left">Outstanding at June 30, 2026</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_d0_c20250101__20250630_zsn5uWE6Amvj" style="text-align: right" title="Warrants outstanding, ending balance">—</td><td style="text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_d0_c20250101__20250630_zaF8fSeD420k" style="font-size: 12pt; text-align: right" title="Weighted average exercise price, ending balance">—</td><td style="font-size: 12pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="vertical-align: bottom; text-align: left">Exercisable at June 30, 2026</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_d0_c20250630_zpasuTGxj9hf" style="text-align: right" title="Warrants outstanding, Exercisable">—</td><td style="text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_d0_c20250630_z9Ga5tM3V5y9" style="font-size: 12pt; text-align: right" title="Weighted average exercise price, Exercisable">—</td><td style="font-size: 12pt; text-align: left"> </td></tr> </table> As of June 30, 2026, 3,146,667 warrants were outstanding and exercisable, with a weighted average exercise price of approximately $0.05 per share. The following table summarizes warrants outstanding at June 30, 2026: <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zzXqz7y93AG4" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details - Warrants outstanding)"> <tr style="vertical-align: bottom"> <td>Schedule of warrants outstanding</td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Grant Date</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Shares Under Warrant</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Expiration Date</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Exercise Terms</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 20%; font-size: 10pt; padding-left: 0.75pt">July 29, 2025</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_di_c20260630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zTDkdaCFOi4h" style="width: 17%; font-size: 10pt; text-align: right" title="Shares under warrant">(2,992,201</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--AwardTypeAxis__custom--WarrantsMember_z4o9piaZKVcb" style="width: 17%; font-size: 10pt; text-align: right" title="Warrant exercise price">0.30</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 19%; font-size: 10pt; text-align: justify; padding-left: 0.75pt">July 29, 2028</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 17%; font-size: 10pt; text-align: right">Cash exercise</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-left: 0.75pt">September 8, 2025</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_di_c20260630__us-gaap--AwardTypeAxis__custom--Warrants1Member_zKIkaAfH7btd" style="font-size: 10pt; text-align: right" title="Shares under warrant">(628,362</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--AwardTypeAxis__custom--Warrants1Member_zOqz5pbbRFD2" style="font-size: 10pt; text-align: right" title="Warrant exercise price">0.10</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: justify; padding-left: 0.75pt">September 8, 2028</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">Cash exercise</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-left: 0.75pt">October 15, 2025</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260630__us-gaap--AwardTypeAxis__custom--Warrants2Member_zMsdPVWTnGP9" style="font-size: 10pt; text-align: right" title="Shares under warrant">280,000</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--AwardTypeAxis__custom--Warrants2Member_z9FyIgVZxyW1" style="font-size: 10pt; text-align: right" title="Warrant exercise price">0.05</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: justify; padding-left: 0.75pt">October 15, 2028</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">Cash exercise</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-left: 0.75pt">November 28, 2025</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260630__us-gaap--AwardTypeAxis__custom--Warrants3Member_zedhoKHDYSv6" style="font-size: 10pt; text-align: right" title="Shares under warrant">628,362</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--AwardTypeAxis__custom--Warrants3Member_zD0weo9cbDx1" style="font-size: 10pt; text-align: right" title="Warrant exercise price">0.05</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: justify; padding-left: 0.75pt">November 28, 2028</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">Cash exercise</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-left: 0.75pt">January 23, 2026</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260630__us-gaap--AwardTypeAxis__custom--Warrants4Member_zsU9Y6YvN2S9" style="font-size: 10pt; text-align: right" title="Shares under warrant">500,000</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--AwardTypeAxis__custom--Warrants4Member_z7Gedwhxoywj" style="font-size: 10pt; text-align: right" title="Warrant exercise price">0.05</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: justify; padding-left: 0.75pt">January 23, 2029</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">Cash exercise</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-left: 0.75pt">January 28, 2026</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260630__us-gaap--AwardTypeAxis__custom--Warrants5Member_zFopq00h56cc" style="font-size: 10pt; text-align: right" title="Shares under warrant">500,000</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--AwardTypeAxis__custom--Warrants5Member_zb5K40KDEBz" style="font-size: 10pt; text-align: right" title="Warrant exercise price">0.05</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: justify; padding-left: 0.75pt">January 28, 2029</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">Cash exercise</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-left: 0.75pt">April 13, 2026</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260630__us-gaap--AwardTypeAxis__custom--Warrants6Member_zgGb3uiXMftj" style="font-size: 10pt; text-align: right" title="Shares under warrant">1,200,000</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--AwardTypeAxis__custom--Warrants6Member_zm0htXi60jCe" style="font-size: 10pt; text-align: right" title="Warrant exercise price">0.015</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: justify; padding-left: 0.75pt">April 13, 2029</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">Cash exercise</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-left: 0.75pt">Total / Weighted Average</td><td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260630_zIFgtTbKWQWi" style="font-size: 10pt; font-weight: bold; text-align: right" title="Shares under warrant">3,146,667</td><td style="font-size: 10pt; font-weight: bold; text-align: left"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630_z0FVCAVuKena" style="font-size: 10pt; font-weight: bold; text-align: right" title="Warrant exercise price">0.05</td><td style="font-size: 10pt; font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: justify; padding-left: 0.75pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table> Weighted Average term remaining: For the current period issuances: 2,200,000 warrants issued during the six months ended June 30, 2026 had a weighted-average remaining contractual term of approximately <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260630_zRGLehq5Hvgd" title="Weighted average remaining contractual term">2.69 years as of June 30, 2026. For the total warrants outstanding at June 30, 2026: 3,146,667 warrants outstanding had a weighted-average remaining contractual term of approximately <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zPDPMWmjc4p5" title="Weighted average remaining contractual term">2.58 years as of June 30, 2026. We have never utilized an underwriter for an offering of our securities. Other than the securities mentioned above and the common stock issuances described below, we have not issued or sold any other securities. During the six months ended June 30, 2026, the Company issued an aggregate of 87,120,000 shares of common stock. The financial statements record an aggregate increase of $87,120 in common stock and $2,964,890 in additional paid-in capital. The Company also recorded a stock subscription receivable of $182,810 as contra-equity, resulting in a net increase in stockholders’ equity of $2,869,200 for these issuances before the effect of net loss.

150000000

0.001

129810580

42690580

87120000

87120

2964890

182810

2869200

129810580

1500000

1000000

500000

1000000

66667

173913

200000

500000

1780000

1500000

280000

1400000

1000000

400000

500000

1200000

2000000

75000000

5920000

182810

129810580

946667

2200000

1200000

0.015

2029-04-13

<table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfStockholdersEquityNoteWarrantsActivityTextBlock_zh2gNF4RQ5Gc" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details - Warrant activity)"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left">Schedule of warrant activity</td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left; font-size: 8pt"> </td><td style="padding-bottom: 1pt; font-size: 8pt"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 64%; font-size: 10pt; text-align: left">Outstanding at December 31, 2025</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20260101__20260630_zQ7X4NUDKzDi" style="width: 14%; font-size: 10pt; text-align: right" title="Warrants outstanding, beginning balance">946,667</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20260101__20260630_zxIeBjuhafF6" style="width: 14%; font-size: 10pt; text-align: right" title="Weighted average exercise price, beginning balance">0.08</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left">Granted</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20260101__20260630_zxVgBF9f0Byj" style="font-size: 10pt; text-align: right" title="Warrants outstanding, Granted">2,200,000</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20260101__20260630_zSjbiCTHvTK2" style="font-size: 10pt; text-align: right" title="Weighted average exercise price, Granted">0.03</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left">Exercised</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_d0_c20260101__20260630_zuxkdIGhOkB" style="font-size: 10pt; text-align: right" title="Warrants outstanding, Granted">—</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_d0_c20260101__20260630_zKdpP8HkGBk3" style="font-size: 10pt; text-align: right" title="Weighted average exercise price, Exercised">—</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left">Expired</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d0_c20260101__20260630_zyy8H73PGiRf" style="font-size: 10pt; text-align: right" title="Warrants outstanding, Expired">—</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d0_c20260101__20260630_zGDBKuGIGPMl" style="font-size: 10pt; text-align: right" title="Weighted average exercise price, Expired">—</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left">Outstanding at June 30, 2026</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20260101__20260630_zlar4Seg0bYf" style="font-size: 10pt; text-align: right" title="Warrants outstanding, ending balance">3,146,667</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20260101__20260630_z2igjONcf518" style="font-size: 10pt; text-align: right" title="Weighted average exercise price, ending balance">0.05</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: left">Exercisable at June 30, 2026</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20260630_zHedKcNCwkz5" style="font-size: 10pt; text-align: right" title="Warrants outstanding, Exercisable">3,146,667</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20260630_ztEyOyK9VWs9" style="font-size: 10pt; text-align: right" title="Weighted average exercise price, Exercisable">0.05</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table> A summary of warrant activity for the six months ended June 30, 2025 is as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: left"> </td><td style="vertical-align: bottom; font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"> </td><td style="vertical-align: bottom; padding-bottom: 1pt; font-size: 8pt; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"> </td><td style="vertical-align: bottom; width: 64%; text-align: left">Outstanding at December 31, 2025</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_d0_c20250101__20250630_zsay2LZlQRPb" style="width: 14%; text-align: right" title="Warrants outstanding, beginning balance">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%; font-size: 12pt"> </td> <td style="width: 1%; font-size: 12pt; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_d0_c20250101__20250630_zsaVHPq4uZAb" style="width: 14%; font-size: 12pt; text-align: right" title="Weighted average exercise price, beginning balance">—</td><td style="width: 1%; font-size: 12pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="vertical-align: bottom; text-align: left">Granted</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20250101__20250630_zdiTH3Pl1RK9" style="text-align: right" title="Warrants outstanding, Granted">—</td><td style="text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20250101__20250630_zcJMcjuqbvrf" style="font-size: 12pt; text-align: right" title="Weighted average exercise price, Granted">—</td><td style="font-size: 12pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td style="vertical-align: bottom; text-align: left">Exercised</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_d0_c20250101__20250630_z4KUgiFTpAWe" style="text-align: right" title="Warrants outstanding, Exercised">—</td><td style="text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_d0_c20250101__20250630_zetBN9SyIVUa" style="font-size: 12pt; text-align: right" title="Weighted average exercise price, Exercised">—</td><td style="font-size: 12pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="vertical-align: bottom; text-align: left">Expired</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d0_c20250101__20250630_zO96tciH2YC4" style="text-align: right" title="Warrants outstanding, Expired">—</td><td style="text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d0_c20250101__20250630_zLdvK6hreJm8" style="font-size: 12pt; text-align: right" title="Weighted average exercise price, Expired">—</td><td style="font-size: 12pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td style="vertical-align: bottom; text-align: left">Outstanding at June 30, 2026</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_d0_c20250101__20250630_zsn5uWE6Amvj" style="text-align: right" title="Warrants outstanding, ending balance">—</td><td style="text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_d0_c20250101__20250630_zaF8fSeD420k" style="font-size: 12pt; text-align: right" title="Weighted average exercise price, ending balance">—</td><td style="font-size: 12pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="vertical-align: bottom; text-align: left">Exercisable at June 30, 2026</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_d0_c20250630_zpasuTGxj9hf" style="text-align: right" title="Warrants outstanding, Exercisable">—</td><td style="text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_d0_c20250630_z9Ga5tM3V5y9" style="font-size: 12pt; text-align: right" title="Weighted average exercise price, Exercisable">—</td><td style="font-size: 12pt; text-align: left"> </td></tr> </table>

946667

0.08

2200000

0.03

0 0

3146667

0.05

3146667

0.05

0 0

3146667

0.05

<table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zzXqz7y93AG4" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details - Warrants outstanding)"> <tr style="vertical-align: bottom"> <td>Schedule of warrants outstanding</td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Grant Date</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Shares Under Warrant</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Expiration Date</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Exercise Terms</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 20%; font-size: 10pt; padding-left: 0.75pt">July 29, 2025</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_di_c20260630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zTDkdaCFOi4h" style="width: 17%; font-size: 10pt; text-align: right" title="Shares under warrant">(2,992,201</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--AwardTypeAxis__custom--WarrantsMember_z4o9piaZKVcb" style="width: 17%; font-size: 10pt; text-align: right" title="Warrant exercise price">0.30</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 19%; font-size: 10pt; text-align: justify; padding-left: 0.75pt">July 29, 2028</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 17%; font-size: 10pt; text-align: right">Cash exercise</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-left: 0.75pt">September 8, 2025</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_di_c20260630__us-gaap--AwardTypeAxis__custom--Warrants1Member_zKIkaAfH7btd" style="font-size: 10pt; text-align: right" title="Shares under warrant">(628,362</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--AwardTypeAxis__custom--Warrants1Member_zOqz5pbbRFD2" style="font-size: 10pt; text-align: right" title="Warrant exercise price">0.10</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: justify; padding-left: 0.75pt">September 8, 2028</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">Cash exercise</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-left: 0.75pt">October 15, 2025</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260630__us-gaap--AwardTypeAxis__custom--Warrants2Member_zMsdPVWTnGP9" style="font-size: 10pt; text-align: right" title="Shares under warrant">280,000</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--AwardTypeAxis__custom--Warrants2Member_z9FyIgVZxyW1" style="font-size: 10pt; text-align: right" title="Warrant exercise price">0.05</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: justify; padding-left: 0.75pt">October 15, 2028</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">Cash exercise</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-left: 0.75pt">November 28, 2025</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260630__us-gaap--AwardTypeAxis__custom--Warrants3Member_zedhoKHDYSv6" style="font-size: 10pt; text-align: right" title="Shares under warrant">628,362</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--AwardTypeAxis__custom--Warrants3Member_zD0weo9cbDx1" style="font-size: 10pt; text-align: right" title="Warrant exercise price">0.05</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: justify; padding-left: 0.75pt">November 28, 2028</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">Cash exercise</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-left: 0.75pt">January 23, 2026</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260630__us-gaap--AwardTypeAxis__custom--Warrants4Member_zsU9Y6YvN2S9" style="font-size: 10pt; text-align: right" title="Shares under warrant">500,000</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--AwardTypeAxis__custom--Warrants4Member_z7Gedwhxoywj" style="font-size: 10pt; text-align: right" title="Warrant exercise price">0.05</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: justify; padding-left: 0.75pt">January 23, 2029</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">Cash exercise</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-left: 0.75pt">January 28, 2026</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260630__us-gaap--AwardTypeAxis__custom--Warrants5Member_zFopq00h56cc" style="font-size: 10pt; text-align: right" title="Shares under warrant">500,000</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--AwardTypeAxis__custom--Warrants5Member_zb5K40KDEBz" style="font-size: 10pt; text-align: right" title="Warrant exercise price">0.05</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: justify; padding-left: 0.75pt">January 28, 2029</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">Cash exercise</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-left: 0.75pt">April 13, 2026</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260630__us-gaap--AwardTypeAxis__custom--Warrants6Member_zgGb3uiXMftj" style="font-size: 10pt; text-align: right" title="Shares under warrant">1,200,000</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--AwardTypeAxis__custom--Warrants6Member_zm0htXi60jCe" style="font-size: 10pt; text-align: right" title="Warrant exercise price">0.015</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: justify; padding-left: 0.75pt">April 13, 2029</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">Cash exercise</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-left: 0.75pt">Total / Weighted Average</td><td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20260630_zIFgtTbKWQWi" style="font-size: 10pt; font-weight: bold; text-align: right" title="Shares under warrant">3,146,667</td><td style="font-size: 10pt; font-weight: bold; text-align: left"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630_z0FVCAVuKena" style="font-size: 10pt; font-weight: bold; text-align: right" title="Warrant exercise price">0.05</td><td style="font-size: 10pt; font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: justify; padding-left: 0.75pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table>

2025-07-29

2992201

0.30

2028-07-29

Cash exercise 2025-09-08

628362

0.10

2028-09-08

Cash exercise 2025-10-15

280000

0.05

2028-10-15

Cash exercise 2025-11-28

628362

0.05

2028-11-28

Cash exercise 2026-01-23

500000

0.05

2029-01-23

Cash exercise 2026-01-28

500000

0.05

2029-01-28

Cash exercise 2026-04-13

1200000

0.015

2029-04-13

Cash exercise

3146667

0.05

2200000

P2Y8M8D

3146667

P2Y6M29D

87120000

87120

2964890

182810

2869200

<p id="xdx_801_ecustom--EquityLineOfCreditAndStockSubscriptionReceivableDisclosureTextBlock_zzKatchqSEa7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0">Note 6 – Equity Line of Credit and Stock Subscription Receivable On January 29, 2026, the Company entered into a Common Stock Purchase Agreement and related Registration Rights Agreement with RH2 Equity Partners, L.P. (the “Investor”), collectively referred to as the equity line of credit agreement. Under the agreement, the Company may, at its sole election and subject to the terms, conditions, and limitations of the agreement, sell and issue to the Investor up to $<span id="xdx_908_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20260127__20260129__us-gaap--TransactionTypeAxis__custom--EquityLineOfCreditAgreementMember_z5v7SRSJDdr" title="Number of value sell">10,000,000 of the Company’s common stock. The Company filed a registration statement on Form S-1 registering the offer and resale of up to <span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260127__20260129__us-gaap--TransactionTypeAxis__custom--EquityLineOfCreditAgreementMember_zS4PpslBxzTf" title="Number of shares sell">20,000,000 shares of common stock issuable to the Investor under the equity line of credit agreement. The registration statement was declared effective by the Securities and Exchange Commission on May 6, 2026. The Board of Directors previously authorized the reservation of 20,000,000 authorized but unissued shares of common stock for issuance under the agreement. On June 21, 2026, the Board of Directors approved Purchase Notice No. 1 and authorized the issuance and sale of <span id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260120__20260121__us-gaap--TransactionTypeAxis__custom--EquityLineOfCreditAgreementMember_zna7vZooh1sd" title="Number of shares sell">5,920,000 shares of the Company’s common stock to the Investor pursuant to the equity line of credit agreement. The Board also authorized the Company’s officers to execute the purchase notice, transfer-agent instructions, issuance forms, and other documents necessary to cause the shares to be issued and delivered to the Investor in direct registration system format. On June 21, 2026, the Company issued <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260120__20260121__us-gaap--TransactionTypeAxis__custom--EquityLineOfCreditAgreementMember_zcby4oloHSL" title="Number of shares sell">5,920,000 shares of common stock to the Investor pursuant to the equity line of credit agreement and recorded aggregate consideration of $<span id="xdx_90D_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20260620__20260621__us-gaap--TransactionTypeAxis__custom--EquityLineOfCreditAgreementMember_zD22tjs0pb8h" title="Aggregate consideration">182,810. The Company recorded $5,920 in common stock, representing the $0.001 par value of the shares issued, and $176,890 in additional paid-in capital. As of June 30, 2026, the Company had not received payment from the Investor for the shares. Accordingly, the Company recorded a stock subscription receivable of $182,810 as a contra-equity account within stockholders’ equity. No cash proceeds related to the issuance were included in the accompanying statement of cash flows for the six months ended June 30, 2026. The issuance is disclosed as a supplemental noncash financing activity. The stock subscription receivable will remain classified as contra-equity until the related consideration is collected. Upon receipt of payment, the Company will reduce the stock subscription receivable and record the corresponding increase in cash.

10000000

20000000

5920000

182810

5920

0.001

176890

182810

Note 7 - Going Concern The Company has incurred recurring losses and, as of June 30, 2026 and December 31, 2025, had accumulated deficits of $4,175,269 and $1,183,067, respectively. In addition, the Company used $141,002 of cash in operating activities during the six months ended June 30, 2026. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to obtain additional financing and achieve profitable operations. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.

-4175269

-1183067

-141002

Note 8 - Income Taxes The Company recognizes deferred income tax assets and liabilities for the expected future tax consequences of events that have been recognized in the financial statements or tax returns. Deferred tax assets and liabilities are determined based on temporary differences between the financial statement carrying amounts and the tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. The components of the Company’s reconciliation of income taxes computed at the statutory rate of 21% to the income tax amount recorded for the six months ended June 30, 2026 and 2025 are as follows: <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zBTzMBWQ1iSk" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details - Reconciliation of income taxes)"> <tr style="vertical-align: bottom"> <td>Schedule of reconciliation of income taxes</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Rate</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">June 30, 2025</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Rate</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Net Loss Before Taxes</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_989_ecustom--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterests_pp0p0_maRate_c20260101__20260630_znZPapxyycX3" style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right" title="Net Loss Before Taxes">628,362</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right">100</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">%</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_982_ecustom--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterests_pp0p0_maRate_c20250101__20250630_zodnQ3rdNOH2" style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right" title="Net Loss Before Taxes">(26,255</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right">100</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt">Tax benefit at federal statutory rate</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pp0p0_maRate_c20260101__20260630_zmYjLNKI5MJj" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Tax benefit at federal statutory rate">(628,362</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_iN_dpi_maratepercentage_c20260101__20260630_zMji8SowemM2" title="Tax benefit at federal statutory rate, Percentage">(21</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)%</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pp0p0_maRate_c20250101__20250630_zKJtqsmNn7x6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Tax benefit at federal statutory rate">(5,514</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_iN_dpi_maratepercentage_c20250101__20250630_zigOQKKPesPg" title="Tax benefit at federal statutory rate, Percentage">(21</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt">State income taxes, net of federal benefit</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_985_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pp0p0_d0_maRate_c20260101__20260630_z666aIm9OaXd" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="State income taxes, net of federal benefit">—</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.0</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_983_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pp0p0_d0_maRate_c20250101__20250630_zKmeLx39cqnc" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="State income taxes, net of federal benefit">—</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.0</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify; padding-left: 5.4pt">Change in valuation allowance</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_989_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pp0p0_maRate_c20260101__20260630_zfsJvnFH6Js7" style="font-size: 10pt; text-align: right" title="Change in valuation allowance">619,710</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_maratepercentage_c20260101__20260630_zUlw4ug10hIg" title="Change in valuation allowance, Percentage">21</td><td style="font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_981_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pp0p0_maRate_c20250101__20250630_zob9P57qSE8c" style="font-size: 10pt; text-align: right" title="Change in valuation allowance">5,514</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_maratepercentage_c20250101__20250630_zY3xFFZlNiyj" title="Change in valuation allowance, Percentage">21</td><td style="font-size: 10pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 2.5pt; padding-left: 5.4pt">Provision from Income Taxes</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td id="xdx_98B_eus-gaap--OtherTaxExpenseBenefit_iT_pp0p0_d0_maRate_c20260101__20260630_zZfkDZNANJa3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Provision from Income Taxes">—</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.0</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td id="xdx_986_eus-gaap--OtherTaxExpenseBenefit_iT_pp0p0_d0_maRate_c20250101__20250630_zdS5WK3509oe" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Provision from Income Taxes">—</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.0</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">%</td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zRgtxQESBxL" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details - Deferred tax asset)"> <tr style="vertical-align: bottom"> <td>Schedule of net deferred tax asset</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Rate</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">June 30, 2025</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Rate</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; font-size: 10pt; text-align: justify; padding-left: 5.4pt">Deferred Tax Asset</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_c20260630_zudnL2XFe9X2" style="width: 12%; font-size: 10pt; text-align: right" title="Deferred Tax Asset">619,710</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 12%; font-size: 10pt; text-align: right">21</td><td style="width: 1%; font-size: 10pt; text-align: left">%</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_986_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_c20251231_za8VqOBvQwyk" style="width: 12%; font-size: 10pt; text-align: right" title="Deferred Tax Asset">5,514</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 12%; font-size: 10pt; text-align: right">21</td><td style="width: 1%; font-size: 10pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify; padding-left: 5.4pt">Less Valuation Allowance</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_988_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20260630_zxhfkBEa0j3" style="font-size: 10pt; text-align: right" title="Less Valuation Allowance">(619,710</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(21</td><td style="font-size: 10pt; text-align: left">)%</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_981_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20251231_zATWHnnGS5yc" style="font-size: 10pt; text-align: right" title="Less Valuation Allowance">(5,514</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(21</td><td style="font-size: 10pt; text-align: left">)%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 2.5pt; padding-left: 5.4pt">Net Deferred Tax Asset</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td id="xdx_98A_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_d0_c20260630_zLJPLP0Yjdw6" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net Deferred Tax Asset">—</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.0</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td id="xdx_982_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_d0_c20251231_z1zFw4CO5pWj" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net Deferred Tax Asset">—</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.0</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">%</td></tr> </table> Because of uncertainties surrounding the Company’s ability to generate future taxable income to realize deferred tax assets, a full valuation allowance has been established. Accordingly, no income tax provision or benefit was recorded for the six months ended June 30, 2026 or 2025.

<table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zBTzMBWQ1iSk" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details - Reconciliation of income taxes)"> <tr style="vertical-align: bottom"> <td>Schedule of reconciliation of income taxes</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Rate</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">June 30, 2025</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Rate</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Net Loss Before Taxes</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_989_ecustom--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterests_pp0p0_maRate_c20260101__20260630_znZPapxyycX3" style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right" title="Net Loss Before Taxes">628,362</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right">100</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">%</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_982_ecustom--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterests_pp0p0_maRate_c20250101__20250630_zodnQ3rdNOH2" style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right" title="Net Loss Before Taxes">(26,255</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right">100</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt">Tax benefit at federal statutory rate</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pp0p0_maRate_c20260101__20260630_zmYjLNKI5MJj" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Tax benefit at federal statutory rate">(628,362</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_iN_dpi_maratepercentage_c20260101__20260630_zMji8SowemM2" title="Tax benefit at federal statutory rate, Percentage">(21</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)%</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pp0p0_maRate_c20250101__20250630_zKJtqsmNn7x6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Tax benefit at federal statutory rate">(5,514</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_iN_dpi_maratepercentage_c20250101__20250630_zigOQKKPesPg" title="Tax benefit at federal statutory rate, Percentage">(21</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt">State income taxes, net of federal benefit</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_985_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pp0p0_d0_maRate_c20260101__20260630_z666aIm9OaXd" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="State income taxes, net of federal benefit">—</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.0</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_983_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pp0p0_d0_maRate_c20250101__20250630_zKmeLx39cqnc" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="State income taxes, net of federal benefit">—</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.0</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify; padding-left: 5.4pt">Change in valuation allowance</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_989_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pp0p0_maRate_c20260101__20260630_zfsJvnFH6Js7" style="font-size: 10pt; text-align: right" title="Change in valuation allowance">619,710</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_maratepercentage_c20260101__20260630_zUlw4ug10hIg" title="Change in valuation allowance, Percentage">21</td><td style="font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_981_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pp0p0_maRate_c20250101__20250630_zob9P57qSE8c" style="font-size: 10pt; text-align: right" title="Change in valuation allowance">5,514</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_maratepercentage_c20250101__20250630_zY3xFFZlNiyj" title="Change in valuation allowance, Percentage">21</td><td style="font-size: 10pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 2.5pt; padding-left: 5.4pt">Provision from Income Taxes</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td id="xdx_98B_eus-gaap--OtherTaxExpenseBenefit_iT_pp0p0_d0_maRate_c20260101__20260630_zZfkDZNANJa3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Provision from Income Taxes">—</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.0</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td id="xdx_986_eus-gaap--OtherTaxExpenseBenefit_iT_pp0p0_d0_maRate_c20250101__20250630_zdS5WK3509oe" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Provision from Income Taxes">—</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.0</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">%</td></tr> </table>

628362 1 -26255 1

-628362

0.21

-5514

0.21

0.000

619710

0.21

5514

0.21

0.000

<table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zRgtxQESBxL" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details - Deferred tax asset)"> <tr style="vertical-align: bottom"> <td>Schedule of net deferred tax asset</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Rate</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">June 30, 2025</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Rate</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; font-size: 10pt; text-align: justify; padding-left: 5.4pt">Deferred Tax Asset</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_c20260630_zudnL2XFe9X2" style="width: 12%; font-size: 10pt; text-align: right" title="Deferred Tax Asset">619,710</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 12%; font-size: 10pt; text-align: right">21</td><td style="width: 1%; font-size: 10pt; text-align: left">%</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_986_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_c20251231_za8VqOBvQwyk" style="width: 12%; font-size: 10pt; text-align: right" title="Deferred Tax Asset">5,514</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 12%; font-size: 10pt; text-align: right">21</td><td style="width: 1%; font-size: 10pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify; padding-left: 5.4pt">Less Valuation Allowance</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_988_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20260630_zxhfkBEa0j3" style="font-size: 10pt; text-align: right" title="Less Valuation Allowance">(619,710</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(21</td><td style="font-size: 10pt; text-align: left">)%</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_981_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20251231_zATWHnnGS5yc" style="font-size: 10pt; text-align: right" title="Less Valuation Allowance">(5,514</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(21</td><td style="font-size: 10pt; text-align: left">)%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 2.5pt; padding-left: 5.4pt">Net Deferred Tax Asset</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td id="xdx_98A_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_d0_c20260630_zLJPLP0Yjdw6" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net Deferred Tax Asset">—</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.0</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td id="xdx_982_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_d0_c20251231_z1zFw4CO5pWj" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net Deferred Tax Asset">—</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.0</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">%</td></tr> </table>

619710

0.21

5514

0.21

619710

-0.21

5514

-0.21

0.000

Note 9 - Subsequent Events In accordance with ASC 855, Subsequent Events, the Company has evaluated subsequent events through the date these financial statements were issued. Management has determined that there were no material subsequent events requiring recognition or disclosure in the financial statements for the quarter ended June 30, 2026.

false false false false